Ontario’s HIV diagnoses are concentrating in groups that routine screening still misses
A retrospective chart review from four Ontario clinical sites shows how the province’s HIV epidemic has shifted toward identifiable subpopulations that continue to face delayed diagnosis and ongoing transmission risk. Among 359 people diagnosed with HIV in Toronto, Ottawa, and Hamilton between January 1, 2018, and December 31, 2020, more than half were immigrants to Canada, and a notable share received their diagnosis during the same year they arrived. The pattern is clinically important because it places HIV testing at the intersection of migration, sexual network risk, and missed opportunities for earlier diagnosis.
Late diagnosis remained common. A total of 43.2% were diagnosed late, a finding that signals ongoing gaps in prevention and case-finding even in large urban centers with established HIV services. In practical terms, late diagnosis means more time for untreated infection, more time for onward transmission, and less chance to deploy pre-exposure prophylaxis, partner services, or rapid linkage to antiretroviral therapy before immune injury advances.
Immigration, recent arrival, and the first years in Canada
The concentration of diagnoses among immigrants deserves close clinical attention. More than half of the cohort had immigrated to Canada, and 11% were diagnosed in the year they arrived. Another 43.2% had no documented HIV testing history in Ontario, which suggests that provincial health-system contact had not consistently translated into routine screening or prevention counseling before diagnosis. In a setting where many people interface with primary care, sexual health clinics, and newcomer services, this is a missed diagnostic window rather than a lack of available tools.
Recent migration can complicate HIV detection for reasons that are clinical, social, and structural at once. New arrivals may have had limited prior access to testing, may not be offered screening promptly, or may face language, stigma, or documentation barriers that delay engagement with preventive care. The data support a targeted approach during the first five years after migration, when testing may be especially likely to uncover undiagnosed infection before advanced disease develops.
Sexually transmitted infections continue to mark higher HIV risk in MSM
Among men who have sex with men, prior bacterial sexually transmitted infections clustered with later HIV diagnosis. A previous diagnosis of gonorrhea or chlamydia appeared in 7.5% of participants, and syphilis in 10.9%. Those are not incidental findings. Rectal, pharyngeal, and genital STIs often travel through the same sexual networks that sustain HIV transmission, and they can increase biological susceptibility through mucosal inflammation while also serving as a visible marker of recent exposure risk.
For clinicians, the lesson is immediate and concrete: a history of syphilis, gonorrhea, or chlamydia should trigger more intensive HIV testing and prevention counseling, especially in MSM. The signal here is not subtle. When a patient has already acquired one sexually transmitted infection, the probability of another exposure in the same network is rarely random, and the opportunity to intervene with regular screening, partner notification, and PrEP can be lost if STI care is handled in isolation from HIV prevention.
Hepatitis C identifies a different risk profile in heterosexual men and women
The risk pattern was not confined to MSM. Among women and heterosexual men, a diagnosis of hepatitis C was associated with HIV diagnosis, affecting 5.0% of the cohort. Hepatitis C in this context likely reflects overlapping vulnerabilities, including injection-related exposures or other shared transmission pathways. It also marks a population that may not always be captured by sexual-network-based HIV screening alone.
This matters because HIV prevention programs frequently sort patients into narrow categories that can miss people whose risk does not fit the most visible stereotypes. Hepatitis C should prompt HIV testing in heterosexual men and women as a routine clinical response, not as an exceptional one. In settings where hepatitis C is identified, HIV status should be reassessed with urgency, and prevention services should follow the same visit rather than being deferred to a future appointment that may never happen.
A provincial strategy built around risk markers rather than broad assumptions
The study’s value lies in how plainly it identifies where Ontario’s HIV prevention efforts can be sharpened. Testing strategies that depend on broad, untargeted outreach will continue to miss people who are already presenting with clinical markers of risk. By contrast, targeted screening based on sexual history, recent bacterial STIs, hepatitis C, and recent immigration could improve case detection and shorten the interval between acquisition and diagnosis.
That approach is especially relevant in urban care networks where clinicians already see the relevant clues. MSM with syphilis, gonorrhea, or chlamydia; heterosexual men and women with hepatitis C; and immigrants within the first five years after arrival all represent groups in which HIV screening can be integrated into routine care rather than treated as a separate public health exercise. When prevention is tied to observable clinical markers, the system is more likely to find infections earlier and connect patients to treatment before further transmission occurs.
The cohort also shows why Ontario’s epidemic cannot be viewed as static. The mix of immigration-related diagnoses, late presentation, and STI-associated risk indicates a shifting transmission pattern rather than a single dominant driver. Public health programs will need to adapt to those changes with screening strategies that are more specific, more proactive, and more closely tied to clinical encounters where risk is already visible.